Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications.
The discovery, research, and development of a pharmaceutical product relies on the availability of validated assays for assessing product characteristics and drug effects in vivo and in vitro. Development of a validated assay is a multifaceted activity that provides many interesting challenges for bioanalytical chemists and statisticians. In this paper, the similarity condition for fundamental validity of an analytic dilution assay is reviewed as a basic concept underlying the validation of assays for pharmaceutical applications. The distinction between the validity and the acceptability of an assay is considered in terms of the characteristics evaluated during four stages of validation. Recent guidelines on the validation of analytical procedures published by the U.S. Food and Drug Administration are appraised from a statistical perspective, and statistical issues in the validation process are discussed.
Smith
W C
WC
Statistical and Mathematical Sciences, Eli Lilly and Company, Greenfield Laboratories, Indiana 46140, USA.
Sittampalam
G S
GS
D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004797:Enzyme-Linked Immunosorbent Assay; D015203:Reproducibility of Results; D013223:Statistics as Topic / Q000379:methods*